购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Ulixertinib

Rating icon 很棒
产品编号 T7005Cas号 869886-67-9
别名 优立替尼, VRT752271, BVD-523

Ulixertinib (VRT752271) 是一种有效且可逆的 ERK1/ERK2 抑制剂,可抑制 ERK2 和下游蛋白 RSK 的磷酸化,对 ERK2 的IC50值小于 0.3 nM。

Ulixertinib

Ulixertinib

Rating icon 很棒
纯度: 99.95%
产品编号 T7005 别名 优立替尼, VRT752271, BVD-523Cas号 869886-67-9

Ulixertinib (VRT752271) 是一种有效且可逆的 ERK1/ERK2 抑制剂,可抑制 ERK2 和下游蛋白 RSK 的磷酸化,对 ERK2 的IC50值小于 0.3 nM。

规格价格库存数量
1 mg¥ 335现货
2 mg¥ 477现货
5 mg¥ 822现货
10 mg¥ 1,330现货
25 mg¥ 2,390现货
50 mg¥ 3,990现货
100 mg¥ 5,680现货
200 mg¥ 7,930现货
500 mg 询价 现货
1 mL x 10 mM (in DMSO)¥ 861现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"Ulixertinib"的相关化合物库

选择批次:
纯度:99.95%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
Ulixertinib (VRT752271) (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
靶点活性
ERK2:<0.3 nM
体外活性
在含有b-RAFV600E突变的A375黑色素瘤细胞株中,Ulixertinib分别以IC50为4.1/0.14 μM降低磷酸化ERK2(pERK)和下游激酶RSK(pRSK)的水平。同时,Ulixertinib以IC50为180 nM抑制A375细胞的增殖。[1]
激酶实验
ERK2 Rapidfire Mass Spectrometry Inhibition of Catalysis Assay: MEK U911-activated ERK2 protein is expressed and purified in-house. Enzyme and substrate solutions are made up in assay buffer consisting of 50 mM Tris (pH 7.5), 10 mM MgCl2, 0.1 mM EGTA, 10 mM DTT and 0.01% (v/v) CHAPS. 1.2 nM ERK2 protein is prepared in assay buffer and 10 μL is dispensed into each well of a polypropylene, 384-well plate containing test and reference control compounds. The compound plates had previously been dosed with a 12 point range from 100 μM down to 0.1 nM in order to calculate compound IC50s, with a total DMSO concentration in the assay of 1%. Following a 20 minute pre-incubation of enzyme and compound at room temperature, 10 μL of substrate solution is added consisting of 16 μM Erktide (IPTTPITTTYFFFK) and 120 μM ATP (measured Km) in assay buffer. The reaction is allowed to progress for 20 minutes at room temperature before being quenched by the addition of 80 μl 1% (v/v) formic acid. The assay plates are then run on the RapidFire Mass Spectrometry platform to measure substrate (unphosphorylated Erktide) and product (phosphorylated Erktide) levels.
细胞实验
A375 cells are cultured in cell media composed of DMEM, 10% (v/v) Foetal Calf Serum and 1% (v/v) L-Glutamine. After harvesting, cells are dispensed into black, 384-well Costar plates to give 200 cells per well in a total volume of 40 μL cell media, and are incubated overnight at 37°C, 90% relative humidity and 5% CO2 in a rotating incubator. Test compounds and reference controls are dosed directly into the cell plates, into the inner 308 wells, using a Labcyte Echo 555 acoustic dispenser. The cells are dosed over a 12 point range from 30 μM down to 0.03 nM in order to calculate compound IC50s, with a total DMSO concentration in the assay of 0.3%. The cell plates are then incubated for 72 hours at 37°C. Cells were fixed and stained by the addition of 20 μL 12% formaldehyde in PBS/A (4% final concentration) and 1:2000 dilution of Hoechst 33342, with a 30 minute room temperature incubation, and then washed with PBS/A. A cell count is performed on the stained cell plates using a Cellomics ArrayScanTM VTI imaging platform. A Day 0 cell plate is also fixed, stained and read to generate a cell count baseline for determining compound cytotoxic effects as well as anti-proliferative effects.(Only for Reference)
别名优立替尼, VRT752271, BVD-523
化学信息
分子量433.33
分子式C21H22Cl2N4O2
CAS No.869886-67-9
SmilesCC(C)Nc1cc(-c2c[nH]c(c2)C(=O)N[C@H](CO)c2cccc(Cl)c2)c(Cl)cn1
密度1.359 g/cm3
储存&溶解度
存储store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 70 mg/mL (161.54 mM)
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 8 mg/mL (18.46 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Ethanol: 12 mg/mL (27.7 mM)
溶液配制表
1mg5mg10mg50mg
1 mM2.3077 mL11.5386 mL23.0771 mL115.3855 mL
5 mM0.4615 mL2.3077 mL4.6154 mL23.0771 mL
10 mM0.2308 mL1.1539 mL2.3077 mL11.5386 mL
1mg5mg10mg50mg
20 mM0.1154 mL0.5769 mL1.1539 mL5.7693 mL
1mg5mg10mg50mg
50 mM0.0462 mL0.2308 mL0.4615 mL2.3077 mL
100 mM0.0231 mL0.1154 mL0.2308 mL1.1539 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Ulixertinib | purchase Ulixertinib | Ulixertinib cost | order Ulixertinib | Ulixertinib chemical structure | Ulixertinib in vitro | Ulixertinib formula | Ulixertinib molecular weight